Life Sciences

Speaker 1: The life science and healthcare industries are leaders in innovation. Technological development is accelerating at a massive pace in both sectors. It's a dynamic time, but also a time of uncertainty.

Lisa Gill: I think that the word disruptive is a word that's synonymous with healthcare today. At JPMorgan, we know the industries well. We know the trends. We know what institutional investors are going to be looking for.

Speaker 1: We know how to help founders raise funds, thrive, and succeed. It's at the core of what we do. We bring decades of experience in advising entrepreneurs and investors around the world, and while many entrepreneurs think they're not ready for JPMorgan, or that they're too small, we believe that while you might be small in size, it doesn't mean you're small in potential. Our commitment, combined with our ability to leverage JPMorgan's global network, allows us to find connections and opportunities for clients and those within our innovation economy ecosystem.

Sam Quinn: One of the reasons we started the life sciences practice is we saw a need in the sector, in the community, in the market for this type of advice.

Speaker 1: JPMorgan focuses on the things we excel at, so our clients can focus on their strengths too. They want a partner that understands what they do and what they think about, such as, "How do I manage my day-to-day operations, excess liquidity, and treasury payments? What can I do to expand my business internationally? And when should I start thinking about an exit plan, for myself and my business?" JPMorgan understands all of this. We're here to help both on the corporate and personal fronts. We'll work with you and your company across your entire lifecycle. That's one of the biggest strengths we offer to life science entrepreneurs and companies. We'll be there for you, from start to finish.